when

Latest
Archive

by source

All Sources
Sources Page

department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Jobs
News

Hubs

Topics
Patent cliff
Publications

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
search

ROCHE · news · pharmadog

← back to ROCHE

News mentioning ROCHE

102 stories

29dRoche Diagnostics growth remains muted amid China headwindsfiercebiotech

29dRoche drops TCE for lupus, but hasn’t given up on autoimmune cell therapiesfiercebiotech

29dGSK lung cancer drug gets speedy approval following $10.6B dealbiopharma dive

29dQ2 earnings underway, FDA’s CRL kerfuffle, IPOs full speed ahead in H2biospace

Jul 21, 26Dimension restocks with $800M to capitalize on AI’s ‘rapid ascent’biopharma dive

Jul 21, 26‘We’ve been looking for a novel approach’: Why Novartis CEO ended ADC holdout for $1.5B Myricx dealfiercebiotech

Jul 21, 26Roche taps Foundation Medicine’s chief as new North America Diagnostics lead, creates new commercial rolefiercebiotech

Jul 20, 26Bristol Myers to build ‘powerful’ AI factory; Samsung Biologics bids for peptide makerbiopharma dive

Jul 20, 26STAT+: Bristol Myers Squibb becomes latest company to claim it’s building pharma’s largest NVIDIA AI supercomputerstat

Jul 20, 26BMS expands AI footprint with Nvidia, aiming for ‘most powerful AI factory in life sciences’fiercebiotech

Jul 14, 26Celcuity wins approval for breast cancer drug Revtorpykendpoints

Jul 14, 26STAT+: Drug metabolism AI competition results show that bigger may not always be betterstat

Jul 13, 26STAT+: Dementia study replicates promising outcomes following risk-reduction strategiesstat

Jul 13, 26STAT+: UnitedHealth’s questionable review, and more MA stars lawsuitsstat

Jul 13, 26STAT+: All eyes on data on Biogen’s tau therapystat

Jul 13, 26STAT+: A breakthrough in pancreatic cancer has experts excited — and braced for what’s to comestat

Jul 12, 26STAT+: Tau in the spotlight at Alzheimer’s conferencestat

Jul 10, 26STAT+: Roche ends Huntington’s gene-silencing programsstat

Jul 9, 26Roche scraps two Ionis-partnered Huntington’s drugsbiopharma dive

Jul 9, 26Roche ends work on tominersen after decade of trials, as well as early-stage Huntington’s assetendpoints

Jul 6, 26STAT+: Vertex acquires Crinetics Pharmaceuticals for $10 billion as biotech M&A boomsstat

Jul 6, 26Roche aims to bolster breast cancer pipeline with early-stage Astex dealendpoints

Jul 6, 26STAT+: Four major biotech updates to catch up onstat

Jul 6, 26STAT+: GOP lawmakers push Trump’s FDA to make sure clinical trials are diversestat

Jul 6, 26STAT+: I spoke to Anthropic’s CEO about how AI may affect biotech. Here’s what I learnedstat

Jul 2, 26STAT+: What does DeGette’s loss mean for pharma?stat

Jul 2, 26A PureTech startup banks $180M for a new IPF drugbiopharma dive

Jul 2, 26Roche KRAS drug succeeds in head-to-head lung cancer studybiopharma dive

Jul 2, 26STAT+: Roche drug sets new standard for KRAS-driven lung cancerstat

Jul 2, 26Roche’s KRAS G12C inhibitor beats rivals in head-to-head Phase 3 studyendpoints

← prevpage 2 of 4next →